Chard Lucy
Future Medicine, Future Science Group Ltd, London, UK.
Epigenomics. 2019 Jan;11(1):1-4. doi: 10.2217/epi-2018-0198.
Foreword by Lucy Chard Welcome to the 11th volume of Epigenomics. I would like to take this opportunity to wish all of our readers a Happy New Year. In this Foreword, I shall be taking a look back at some of the journal highlights of 2018. Over the past year, we have seen some great strides in the development of epigenetics for medical applications. However, this advancing field, while niche, still needs to overcome a number of obstacles before we see a more widespread application of this technology. It has been a privilege for Epigenomics to publish work in this fascinating field, which continues to be of the highest quality.
露西·查德前言 欢迎阅读《表观基因组学》第11卷。我想借此机会祝所有读者新年快乐。在这篇前言中，我将回顾2018年本刊的一些亮点。在过去的一年里，我们看到表观遗传学在医学应用的发展方面取得了一些巨大进展。然而，这个不断发展的领域虽然小众，但在我们看到这项技术更广泛应用之前，仍需要克服一些障碍。《表观基因组学》能够在这个迷人的领域发表高质量的作品，是一种荣幸。
